Continuing Sodium Zirconium Cyclosilicate (SZC) after discharge study

Trial Identifier: D9480C00023
Sponsor: AstraZeneca
NCTID:: NCT05347693
Start Date: March 2022
Primary Completion Date: September 2024
Study Completion Date: September 2024
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
BE Belgium, BE, 1200
BE Bonheiden, BE, 2820
BE Dendermonde, BE, 9200
BE Leuven, BE, 3000
BE Lodelinsart, BE, 6042
DE Kaiserslautern, DE, 67655
ES Alicante, ES, 03010
ES Almería, ES, 04009
ES Badajoz, ES, 06080
ES Barcelona, ES, 08907
ES Burgos, ES, 9006
ES Getafe, ES, 28905
ES Madrid, ES, 28006
ES Palma de Mallorca, ES, 7120
ES San Sebastián de los Reyes, ES, 28702
ES Santiago de Compostela, ES, 15706
ES Sevilla, ES, 41009
FR ANNONAY, FR, 07103
FR Ars-Laquenexy, FR, 57530
FR La Tronche, FR, 38043
FR Nice, FR, 06000
FR SAINT-PRIEST EN JAREZ, FR, 42270
GB CARDIFF, GB, CF14 4XW
GB Doncaster, GB, DN2 5LT
GB Edinburgh, GB, EH16 4SA
GB Hull, GB, HU10 7AZ
GB Leicester, GB, LE5 4PW
GB London, GB, 6BQ
GB Salford, GB, M6 8HD
GB Stevenage, GB, SG1 4AB
GB York, GB, YO31 8HE
IT Acireale, IT, 95024
IT Bari, IT, 70124
IT Foggia, IT, 71122
IT Parma, IT, 43126
IT Pavia, IT, 27100
IT Roma, IT, 00163
NL Amsterdam, NL, 1105AZ
NL Eindhoven, NL, 5602 ZA
NL Groningen, NL, 9700 RB
NL Rotterdam, NL, 3015 CE